Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:34 am Sale |
2022-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
Deep Track Capital, LP | 0 0.000% |
-3,646,690 (Position Closed) |
Filing History |
| 2023-02-09 10:59 am Sale |
2023-02-09 | 13G | Global Blood Therapeutics, Inc. GBT |
FMR CORP | 278,419 0.410% |
-4,318,972 (-93.94%) |
Filing History |
| 2022-06-17 4:04 pm Purchase |
2022-06-10 | 13G | Global Blood Therapeutics, Inc. GBT |
Deep Track Capital, LP | 3,646,690 5.600% |
3,646,690 (New Position) |
Filing History |
| 2022-02-14 4:46 pm Sale |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
Point72 Asset Management, L.P. | 225,463 0.300% |
-2,999,111 (-93.01%) |
Filing History |
| 2022-02-14 4:14 pm Purchase |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
Baker Bros. Advisors LP | 3,314,765 5.100% |
3,314,765 (New Position) |
Filing History |
| 2022-02-14 3:50 pm Sale |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
PERCEPTIVE ADVISORS LLC | 3,449,915 5.400% |
-2,224,796 (-39.21%) |
Filing History |
| 2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
PRICE T ROWE ASSOCIATES INC | 3,260,685 5.000% |
-802,438 (-19.75%) |
Filing History |
| 2022-02-10 4:06 pm Sale |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
JANUS HENDERSON GROUP PLC JHG |
5,483,164 8.500% |
-789,518 (-12.59%) |
Filing History |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
The Vanguard Group | 5,993,142 9.300% |
532,660 (+9.75%) |
Filing History |
| 2022-02-09 09:19 am Purchase |
2022-02-08 | 13G | Global Blood Therapeutics, Inc. GBT |
FMR CORP | 4,597,391 7.099% |
3,370,553 (+274.73%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
BLACKROCK INC BLK |
5,353,056 8.300% |
1,669,796 (+45.33%) |
Filing History |
| 2022-01-31 3:15 pm Sale |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
BANK OF AMERICA CORP BAC |
1,603,685 2.500% |
-4,279,893 (-72.74%) |
Filing History |
| 2021-10-12 12:47 pm Purchase |
2021-09-30 | 13G | Global Blood Therapeutics, Inc. GBT |
JANUS HENDERSON GROUP PLC JHG |
6,272,682 10.100% |
305,820 (+5.13%) |
Filing History |
| 2021-05-13 4:34 pm Purchase |
2021-05-04 | 13G | Global Blood Therapeutics, Inc. GBT |
Point72 Asset Management, L.P. | 3,224,574 5.200% |
2,797,541 (+655.11%) |
Filing History |
| 2021-05-10 1:11 pm Sale |
2021-05-07 | 13G | Global Blood Therapeutics, Inc. GBT |
FMR CORP | 1,226,838 1.970% |
-3,180,227 (-72.16%) |
Filing History |
| 2021-02-16 3:35 pm Sale |
2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
PERCEPTIVE ADVISORS LLC | 5,674,711 9.200% |
-191,015 (-3.26%) |
Filing History |
| 2021-02-16 12:23 pm Sale |
2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
PRICE T ROWE ASSOCIATES INC | 4,063,123 6.500% |
-1,593,062 (-28.16%) |
Filing History |
| 2021-02-12 3:25 pm Purchase |
2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
JANUS HENDERSON GROUP PLC JHG |
5,966,862 9.700% |
3,443,594 (+136.47%) |
Filing History |
| 2021-02-10 10:57 am Sale |
2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
The Vanguard Group | 5,460,482 8.840% |
-10,980 (-0.20%) |
Filing History |
| 2021-02-08 5:14 pm Purchase |
2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
BANK OF AMERICA CORP BAC |
5,883,578 9.500% |
1,185,435 (+25.23%) |
Filing History |